Stephen A. Tullman has bought ACRS on 4 days since Apr 2018
Director at Aclaris Therapeutics, Inc.
SEC CIK 0001654343 · Filings on SEC.gov ↗
$740KBought
$0Sold
Oct 5Last buy
Stephen A. Tullman's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
4 filings since Apr 2018, newest first
Filings come from SEC EDGAR. Not investment advice.